Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents

被引：0
|
作者：
Hideaki Miyake
Ryo Sato
Kyohei Watanabe
Yuto Matsushita
Hiromitsu Watanabe
Daisuke Motoyama
Toshiki Ito
Takayuki Sugiyama
Atsushi Otsuka
机构：
[1] Hamamatsu University School of Medicine,Department of Urology
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Metastatic castration-resistant prostate cancer; Cabazitaxel; Third-line treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1745 / 1751
页数：6
相关论文
共 50 条
  • [11] TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer
    Oudard, Stephane
    FUTURE ONCOLOGY, 2011, 7 (04) : 497 - 506
  • [12] Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer
    Kreis, Kristine
    Horenkamp-Sonntag, Dirk
    Schneider, Udo
    Zeidler, Jan
    Glaeske, Gerd
    Weissbach, Lothar
    BJU INTERNATIONAL, 2022, 129 (04) : 470 - 479
  • [13] Clinical concepts for cabazitaxel in the management of metastatic castration-resistant prostate cancer
    Al-Mansouri, Loma
    Gurney, Howard
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (06) : 288 - 295
  • [14] Optimal Timing of Cabazitaxel Introduction for Japanese Patients With Metastatic Castration-resistant Prostate Cancer
    Ito, Toshiki
    Kanao, Kent
    Takahara, Kiyoshi
    Ando, Ryosuke
    Yasui, Takahiro
    Shiroki, Ryoichi
    Sumitomo, Makoto
    Miyake, Hideaki
    ANTICANCER RESEARCH, 2019, 39 (06) : 3089 - 3094
  • [15] Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer
    Thibault, Constance
    Eymard, Jean-Christophe
    Birtle, Alison
    Krainer, Michael
    Baciarello, Giulia
    Flechon, Aude
    Le Moulec, Sylvestre
    Spaeth, Dominique
    Laguerre, Brigitte
    Caffo, Orazio
    Deville, Jean-Laurent
    Beuzeboc, Phillipe
    Hasbini, Ali
    Gross-Goupil, Marine
    Helissey, Carole
    Bennamoun, Mostefa
    Hardy-Bessard, Anne-Claire
    Oudard, Stephane
    EUROPEAN JOURNAL OF CANCER, 2018, 97 : 41 - 48
  • [16] Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry
    Notohardjo, Jessica C. L.
    Kuppen, Malou C. P.
    Westgeest, Hans M.
    van Moorselaar, Reindert J. A.
    Mehra, Niven
    Coenen, Jules L. L. M.
    van Oort, Inge M.
    de Vos, Aad, I
    Vervenne, Walter L.
    van den Bergh, Alphons C. M.
    Aben, Katja K. H.
    Somford, Diederik M.
    Bergman, Andries M.
    Uyl-de Groot, Carin A.
    Gerritsen, Winald R.
    van den Eertwegh, Alfons J. M.
    EUROPEAN UROLOGY FOCUS, 2021, 7 (04): : 788 - 796
  • [17] Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review
    Finn Edler von Eyben
    Giandomenico Roviello
    Timo Kiljunen
    Christian Uprimny
    Irene Virgolini
    Kalevi Kairemo
    Timo Joensuu
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 496 - 508
  • [18] Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review
    von Eyben, Finn Edler
    Roviello, Giandomenico
    Kiljunen, Timo
    Uprimny, Christian
    Virgolini, Irene
    Kairemo, Kalevi
    Joensuu, Timo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (03) : 496 - 508
  • [19] Cabazitaxel after docetaxel: a new option in metastatic castration-resistant prostate cancer
    Lheureux, Stephanie
    Joly, Florence
    BULLETIN DU CANCER, 2012, 99 (09) : 875 - 880
  • [20] Prolonged Therapy With Cabazitaxel in an Octogenarian With Metastatic Castration-Resistant Prostate Cancer
    Pal, Sumanta K.
    Stein, Cy A.
    CLINICAL GENITOURINARY CANCER, 2012, 10 (04) : 274 - 276
12345